Editorial: Systemic involvement in obstructive sleep apnea: Personalized medicine to improve health outcomes
GL declares grant support from the National Institute of Health (1R21HL161766-01) and the American Academy of Sleep Medicine (254-FP-21).
| Autores: | , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2022 |
| País: | España |
| Institución: | Universitat de Lleida (UdL) |
| Repositorio: | Repositori Obert UdL |
| OAI Identifier: | oai:repositori.udl.cat:10459.1/83902 |
| Acceso en línea: | https://doi.org/10.3389/fmed.2022.999977 http://hdl.handle.net/10459.1/83902 |
| Access Level: | acceso abierto |
| Palabra clave: | Obstructive sleep apnea Sleep apnea Sleep apnea and cardiovascular diseases Precision medicine Hypoxemia obstructive sleep apnea, sleep apnea, sleep apnea and cardiovascular diseases, precision medicine, hypoxemia |
| Sumario: | GL declares grant support from the National Institute of Health (1R21HL161766-01) and the American Academy of Sleep Medicine (254-FP-21). |
|---|